Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Mise à jour : Il y a 4 ans
Référence : NCT01634503

Femme Homme

Extrait

This study is to determine maximum tolerable dose (MTD) of GX 188E by defining the safety profile the safety and maximum tolerated dose of GX-188E administered by electroporation in Cervical Intraepithelial Neoplasia grade 3 (CIN 3) patients.


Critère d'inclusion

  • Cervical intraepithelial neoplasia 3

Liens